01.12.2015 | Research article | Ausgabe 1/2015 Open Access

Profiles of responses of immunological factors to different subtypes of Kawasaki disease
- Zeitschrift:
- BMC Musculoskeletal Disorders > Ausgabe 1/2015
Competing interests
Authors’ contributions
Background
Methods
Subjects
Controls
The diagnostic criteria for KD
The diagnosis of incomplete KD
The diagnostic criteria of the coronary artery lesions (CAL)
The criteria for a prodromal infection
The treatment of patients with KD
The criteria of both sensitive and non-reactive KD for intravenous immunoglobulin (IVIG) therapy
Specimen collection
Instruments and reagents
Detection via flow cytometry
Statistical analysis
Results
Study participants
KD cases
|
Mean age
|
Girls %
|
Prodromal infection
|
Typical KD
|
CAL
|
Respond to IVIG
|
---|---|---|---|---|---|---|
388
|
2.30 years
|
32.47 %
|
54.0 %
|
96.13 %
|
25.78 %
|
93.81 %
|
KD group
|
Febrile control
|
Normal control
|
||||
---|---|---|---|---|---|---|
subsets
|
N
|
Age
|
N
|
Age
|
N
|
Age
|
all cases
|
388
|
2.30 ± 1.99
|
160
|
2.43 ± 2.20
|
85
|
2.49 ± 1.89
|
male
|
262
|
2.25 ± 2.02
|
104
|
2.24 ± 2.09
|
54
|
2.23 ± 1.35
|
female
|
126
|
2.40 ± 1.93
|
56
|
2.79 ± 2.37
|
31
|
2.96 ± 2.53
|
prodromal infection
|
213
|
2.18 ± 2.02
|
||||
no prodromal infection
|
175
|
2.44 ± 1.95
|
||||
typical KD
|
373
|
2.29 ± 1.98
|
||||
incomplete KD
|
15
|
2.56 ± 2.23
|
||||
CAL
|
100
|
2.46 ± 2.17
|
||||
Non-CAL
|
288
|
2.24 ± 1.93
|
||||
IVIG sensitive
|
364
|
2.30 ± 1.94
|
||||
IVIG nonresponsive
|
24
|
2.33 ± 2.71
|
A comparison of the lymphocyte subsets among the KD, febrile and normal control groups
Group
|
n
|
CD3
|
CD4
|
CD8
|
CD16 CD56
|
CD19
|
CD4/CD8
|
---|---|---|---|---|---|---|---|
KD group (count/μl)
|
388
|
2177.68 ± 1361.88**
††
|
1360.66 ± 914.86**
|
694.96 ± 492.43
††
|
312.14 ± 291.27
††
|
1218.80 ± 803.16**
†
|
|
Febrile group (count/μl)
|
160
|
2680.22 ± 2105.36**
|
1496.28 ± 1179.19**
|
1068.54 ± 1220.52**
|
428.56 ± 430.11
|
1046.73 ± 863.80**
|
|
Normal group (count/μl)
|
85
|
1765.88 ± 656.00
|
890.09 ± 363.65
|
724.53 ± 299.90
|
369.38 ± 232.85
|
539.92 ± 257.89
|
|
KD group (%)
|
388
|
56.23 ± 10.50**
††
|
35.09 ± 9.28**
|
18.12 ± 6.50**
††
|
8.23 ± 5.47**
††
|
32.88 ± 11.27**
††
|
2.27 ± 1.13**
††
|
Febrile group (%)
|
160
|
62.08 ± 11.30
|
34.70 ± 9.08**
|
24.07 ± 9.27**
|
10.18 ± 5.66**
|
25.27 ± 10.51**
|
1.63 ± 0.71**
|
Normal group (%)
|
85
|
64.09 ± 6.89
|
32.01 ± 4.66
|
26.46 ± 4.96
|
13.45 ± 5.96
|
19.75 ± 5.00
|
1.25 ± 0.30
|
A comparison of the immunoglobulins among the KD, Febrile and normal control groups
Group
|
n
|
IgG
|
IgA
|
IgM
|
C
3
|
C
4
|
---|---|---|---|---|---|---|
KD group (g/L)
|
388
|
7.13 ± 3.00
††
|
0.77 ± 0.49**
|
1.29 ± 0.64
|
1.28 ± 0.24**
††
|
0.27 ± 0.09
††
|
Febrile group (g/L)
|
160
|
8.02 ± 2.93**
|
0.75 ± 0.58*
|
1.28 ± 0.53
|
1.14 ± 0.28**
|
0.30 ± 0.13*
|
Normal group (g/L)
|
85
|
7.21 ± 1.48
|
0.63 ± 0.34
|
1.15 ± 0.44
|
1.01 ± 0.21
|
0.28 ± 0.09
|
A comparison of the lymphocyte subsets and the immunoglobulins between the typical KD group and the incomplete KD group
Group
|
n
|
CD3
|
CD4
|
CD8
|
CD16 CD56
|
CD19
|
CD4/CD8
|
---|---|---|---|---|---|---|---|
Typical KD (count/μl)
|
373
|
2144.26 ± 1355.17*
|
1341.05 ± 915.06*
|
683.15 ± 487.67*
|
306.75 ± 291.09
|
1220.17 ± 807.47
|
2.28 ± 1.15
|
Incomplete KD (count/μl)
|
15
|
3008.73 ± 1304.49
|
1848.13 ± 788.68
|
988.47 ± 536.45
|
446.07 ± 271.47
|
1184.80 ± 710.88
|
2.03 ± 0.71
|
Typical KD (%)
|
373
|
55.92 ± 10.49**
|
34.92 ± 9.36
|
17.99 ± 6.48
|
8.19 ± 5.53
|
33.27 ± 11.26**
|
|
Incomplete KD (%)
|
15
|
64.00 ± 7.41
|
39.33 ± 5.61
|
21.20 ± 6.54
|
9.27 ± 3.73
|
23.40 ± 6.41
|
Group
|
n
|
IgG
|
IgA
|
IgM
|
C
3
|
C
4
|
---|---|---|---|---|---|---|
Typical KD (g/L)
|
373
|
7.12 ± 3.05
|
0.78 ± 0.50
|
1.29 ± 0.64
|
1.28 ± 0.25
|
0.27 ± 0.09
|
Incomplete KD (g/L)
|
15
|
7.39 ± 1.62
|
0.70 ± 0.35
|
1.29 ± 0.48
|
1.25 ± 0.23
|
0.29 ± 0.08
|
A comparison of the lymphocyte subsets and the immunoglobulins between the IVIG nonresponsive group and the IVIG sensitive group
Group
|
n
|
CD3
|
CD4
|
CD8
|
CD16 CD56
|
CD19
|
CD4/CD8
|
---|---|---|---|---|---|---|---|
IVIG sensitive (count/μl)
|
364
|
2235.66 ± 1334.14**
|
1396.26 ± 906.23**
|
713.22 ± 480.79**
|
320.29 ± 287.96*
|
1240.26 ± 808.21*
|
2.25 ± 1.12
|
IVIG nonresponsive (count/μl)
|
24
|
1298.38 ± 1501.81
|
820.75 ± 892.87
|
417.92 ± 588.64
|
188.49 ± 319.00
|
893.38 ± 653.29
|
2.48 ± 1.29
|
IVIG sensitive (%)
|
364
|
56.80 ± 10.08**
|
35.39 ± 9.21*
|
18.34 ± 6.43**
|
8.37 ± 5.53
|
32.23 ± 10.75**
|
|
IVIG nonresponsive (%)
|
24
|
47.71 ± 13.04
|
30.50 ± 9.19
|
14.75 ± 6.73
|
6.18 ± 4.03
|
42.83 ± 14.25
|
Group
|
n
|
IgG
|
IgA
|
IgM
|
C
3
|
C
4
|
---|---|---|---|---|---|---|
IVIG sensitive (g/L)
|
364
|
7.11 ± 2.86
|
0.77 ± 0.48
|
1.28 ± 0.54
|
1.29 ± 0.24*
|
0.27 ± 0.09
|
IVIG nonresponsive (g/L)
|
24
|
7.50 ± 4.79
|
0.76 ± 0.61
|
1.47 ± 1.48
|
1.14 ± 0.28
|
0.24 ± 0.08
|
A comparison of the lymphocyte subsets and the immunoglobulins between the CAL group and the non-CAL group
Group
|
n
|
CD3
|
CD4
|
CD8
|
CD16 CD56
|
CD19
|
CD4/CD8
|
---|---|---|---|---|---|---|---|
CAL (count/μl)
|
100
|
2067.04 ± 1369.82
|
1296.81 ± 903.35
|
630.54 ± 481.71
|
269.18 ± 243.26
|
1239.31 ± 896.90
|
2.40 ± 1.35
|
Non-CAL (count/μl)
|
288
|
2216.10 ± 1359.39
|
1382.83 ± 919.34
|
717.32 ± 494.96
|
327.05 ± 305.16
|
1211.68 ± 769.50
|
2.22 ± 1.05
|
CAL (%)
|
100
|
55.42 ± 11.00
|
34.86 ± 8.99
|
17.21 ± 6.80
|
7.45 ± 4.57
|
34.50 ± 12.95
|
|
Non-CAL (%)
|
288
|
56.52 ± 10.32
|
35.17 ± 9.39
|
18.43 ± 6.37
|
8.50 ± 5.73
|
32.32 ± 10.59
|
Group
|
n
|
IgG
|
IgA
|
IgM
|
C
3
|
C
4
|
---|---|---|---|---|---|---|
CAL (g/L)
|
100
|
7.40 ± 3.25
|
0.80 ± 0.48
|
1.43 ± 0.91
|
1.27 ± 0.25
|
0.26 ± 0.08
|
Non-CAL (g/L)
|
288
|
7.04 ± 2.91
|
0.76 ± 0.49
|
1.24 ± 0.50
|
1.29 ± 0.24
|
0.28 ± 0.09
|
A comparison of the lymphocyte subsets and the immunoglobulins between the infection group and the non-infection group
Group
|
n
|
CD3
|
CD4
|
CD8
|
CD16 CD56
|
CD19
|
CD4/CD8
|
---|---|---|---|---|---|---|---|
Infection (count/μl)
|
213
|
2220.21 ± 1453.05
|
1407.65 ± 980.84
|
706.04 ± 520.13
|
290.24 ± 273.03
|
1231.98 ± 831.04
|
2.29 ± 1.13
|
Non-infection (count/μl)
|
175
|
2125.92 ± 1244.10
|
1303.46 ± 826.67
|
681.47 ± 457.58
|
338.78 ± 310.76
|
1202.77 ± 769.93
|
2.24 ± 1.13
|
Infection (%)
|
213
|
56.39 ± 10.60
|
35.38 ± 9.33
|
18.05 ± 6.42
|
7.92 ± 5.72
|
33.15 ± 11.49
|
|
Non-infection (%)
|
175
|
56.05 ± 10.40
|
34.74 ± 9.23
|
18.20 ± 6.61
|
8.60 ± 5.15
|
32.56 ± 11.01
|
Group
|
n
|
IgG
|
IgA
|
IgM
|
C
3
|
C
4
|
---|---|---|---|---|---|---|
Infection (g/L)
|
213
|
7.01 ± 3.20
|
0.75 ± 0.50
|
1.27 ± 0.53
|
1.25 ± 0.23**
|
0.26 ± 0.08**
|
Non-infection (g/L)
|
175
|
7.28 ± 2.75
|
0.80 ± 0.48
|
1.32 ± 0.74
|
1.32 ± 0.26
|
0.29 ± 0.09
|